(Those who contract dengue fever experience parching thirst – but with so many fewer falling sick, the demand for the Blue Raspberry's rehydrating power has fallen away).
Patients with dengue can experience a variety of serious complications including hypovolemic shock, thrombocytopenia, and bleeding.
Although most individuals infected with the dengue virus experience asymptomatic or mild febrile illness, some develop dengue haemorrhagic fever (DHF) or shock (DSS) which can be fatal.
Other countries already intensely affected by dengue may experience much earlier increases in the transmission range and intensity of vector-borne disease than is expected for Australia, and will be thus be subject to contemporary medical technology and therapy.
Both sites experience dengue burden with Maynas typically having higher Ae. aegypti population densities and dengue transmission rates than Tupac Amaru: the 1999 age adjusted seroprevalence rates for dengue were 89% and 69%, respectively.
Few patients experience Dengue Shock Syndrome, which includes a sudden onset after a fever of 2-7 days long, frank bleeding, cool skin, faint blood pressure, and circulatory failure.
This might due to the fact that adults usually do not go to hospital at the beginning of their illness, so samples were collected from them later than from younger patients, and older patients are more likely to have experienced dengue infection previously than younger patients.
However, among the 55 dengue patients who experienced severe bleeding, most (40 patients, 73%) did not have shock.
In areas hyperendemic for dengue with clinicians experienced in diagnosis and management of dengue fever and DHF, death rates are relatively low (3, 4 ).
